Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Quantitative Molecular Diagnostic Methods Identify Causes of Childhood Diarrhea

By LabMedica International staff writers
Posted on 06 Oct 2016
The number of cases of childhood diarrhea attributed to pathogens such as bacteria, parasites, viruses or other infections has been substantially underestimated and may be nearly twice as high as previous analysis suggests.

Worldwide, diarrhea remains the second leading cause of death in children under five years old, and is associated with approximately half a million deaths per year. More...
Management of diarrhea usually involves supportive care with rehydration and zinc supplementation. Antibiotics are not usually recommended unless there are signs of dysentery, severe diarrhea with the presence of blood and mucus in the stools or if cholera is suspected.

A large team of scientists collaborating with those at the University of Virginia (Charlottesville, VA, USA) re-analyzed stool samples from 10.608 children with and without diarrhea obtained from regions in seven countries in Asia (Bangladesh, India and Pakistan) and Africa (The Gambia, Kenya, Mali, and Mozambique), which were from the Global Enteric Multicenter Study (GEMS). Previous estimates of the infectious causes of diarrhea were based on a variety of different detection methods, but this study, for the first time, uses a molecular diagnostic testing method called quantitative real-time polymerase chain reaction (qPCR) to test for 32 pathogens.

The scientists formulated a custom TaqMan Array Card (Thermo Fisher, Carlsbad, CA, USA) that compartmentalized probe-based qPCR assays for 32 enteropathogens. This platform has shown high reproducibility within and across sites. All the assays have been described previously and have been extensively validated. Nucleic acid was extracted with the QIAamp Fast DNA Stool mini kit (Qiagen, Hilden, Germany) with pretreatment steps that included bead beating.

The original GEMS study1, published in 2013, estimated that 51.5% of childhood diarrhea cases could be attributed to pathogens, but the new re-analysis finds the proportion is much higher at 89.3%. The original study identified four major pathogens: rotavirus, Shigella spp, Cryptosporidium spp, and heat-stable enterotoxin-producing Escherichia coli (ST-ETEC). This re-analysis reaffirmed these four and added two others: adenovirus 40/41 and Campylobacter jejuni/coli. Together, these six pathogens accounted for 77.8% of all diarrheas. Among the children who had a diarrhea-causing pathogen, about half had more than one infection highlighting the challenges of treating multiple infections.

Eric R Houpt, MD, a professor of Infectious Diseases and a senior author of the study said, “Childhood diarrhea remains an enormous problem, made more confusing by the long list of possible infections, the difficulties in diagnosis, and the large number of undiagnosed cases. We developed sensitive quantitative methods that levelled the diagnostic playing field and closed the diagnostic gap.” The study was published on September 24, 2016, in the journal The Lancet.

Related Links:
University of Virginia
Thermo Fisher Scientific
Qiagen

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.